Prosecution Insights
Last updated: May 29, 2026
Application No. 18/316,979

Sulfonium-Salt-Type Polymerizable Monomer, Polymer Photoacid Generator, Base Rein, Resist Composition, And Patterning Process

Non-Final OA §102§103
Filed
May 12, 2023
Priority
May 17, 2022 — JP 2022-81150
Examiner
CHACKO DAVIS, DABORAH
Art Unit
1737
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shin-Etsu Chemical Co. Ltd.
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
698 granted / 973 resolved
+6.7% vs TC avg
Strong +21% interview lift
Without
With
+20.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
26 currently pending
Career history
1014
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
48.0%
+8.0% vs TC avg
§102
22.4%
-17.6% vs TC avg
§112
17.4%
-22.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 973 resolved cases

Office Action

§102 §103
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 3, and 5-19, is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by U. S. Patent Application Publication No. 2022/0107560 (hereinafter referred to as Fukushima). Fukushima, in the abstract, in [0024]-[0032], and [0036], discloses a resist composition comprising a sulfonium salt as a photoacid generator, the sulfonium salt has the claimed structure, see below, PNG media_image1.png 93 282 media_image1.png Greyscale , wherein the hydrocarbyl group that is bound to the sulfonium ion that comprises the aryl group (disclosed above) includes an acid labile group substitution (claimed [O-RALU]) and includes a fluorinated group as further substitution, see below, PNG media_image2.png 166 152 media_image2.png Greyscale , PNG media_image3.png 147 149 media_image3.png Greyscale , PNG media_image4.png 146 156 media_image4.png Greyscale , PNG media_image5.png 143 147 media_image5.png Greyscale , PNG media_image6.png 152 143 media_image6.png Greyscale , and the R2 is a hydrocarbyl group (claimed R11), and the X- group disclosed above is an anion that includes a polymerizable group (claim 1). Fukushima, in [0029]-[0033], discloses that the anion (claimed counterion) having the polymerizable group, has the following structure, see below, PNG media_image7.png 108 238 media_image7.png Greyscale , wherein X1, X2, and L4, are each either a single bond or methylene or phenylene or carbonyl or ester group and Q1, Q2, Q3, and Q4, are each fluorine or fluorinated alkyl groups and is the same as the claimed structure recited in claim 3. Fukushima, in [0036]-[0037[, discloses that the resist composition comprises a base polymer (base resin) with repeat units wherein the repeat units include the repeat unit of the photoacid generator comprising the sulfonium salt (i.e., photoacid generator is a copolymer), see below, PNG media_image8.png 254 233 media_image8.png Greyscale (claims 5-6, and 9). Fukushima, in [0035]-[0036], discloses that the resist composition comprising the base polymer includes the following repeat units, see below, PNG media_image9.png 262 138 media_image9.png Greyscale , wherein Y1, and Y2, are the same as the claimed ZA, and ZB, and includes single bond or phenylene or a -C(=O)-O-Y11, wherein the Y11 includes C1-C10 alkanediyl or phenylene or naphthalene group, and is the same claimed repeat units recited (claims 7, and 10). Fukushima, in [0035], and [0038], discloses a resist composition that comprises the base polymer includes further repeats, see below, PNG media_image10.png 117 127 media_image10.png Greyscale , PNG media_image11.png 138 145 media_image11.png Greyscale , wherein Ap is a polar group and is the same as the claimed YA, and is the same as the repeat units recited (claims 8, and 11). Fukushima, in [0120], discloses that the resist composition further comprises another photoacid generator (other than the sulfonium salt pendant repeat unit of the base polymer), a quencher, and a surfactant (that is insoluble or substantially insoluble in water or alkaline developer), and an organic solvent (see [0118]) (claims 12-15). Fukushima, in [0042], discloses that the resist composition is coated on a substrate to form a resist film, exposing a selective region to EB or EUV (high energy rays), developing the exposed resist film (claims 16-17). Fukushima, in [0043], discloses that the developing can be in an alkaline aqueous developer to form a positive pattern (dissolves exposed region away leaving behind the unexposed region to form the pattern) (claim 18). Fukushima, in [0044], discloses that the developing can be in an organic solvent to form the negative pattern (unexposed region of the resist film dissolved away leaving the exposed region to form the pattern) (claim 19). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2, and 4, is/are rejected under 35 U.S.C. 103 as being unpatentable over U. S. Patent Application Publication No. 2022/0107560 (hereinafter referred to as Fukushima) in view of U. S. Patent Application Publication No. 2021/0188770 (hereinafter referred to as Fujiwara). Fukushima is discussed in paragraph no. 3, above. Fukushima, in the abstract, in [0024]-[0032], and [0036], discloses a sulfonium salt structure, PNG media_image12.png 104 262 media_image12.png Greyscale , wherein the hydrocarbyl group that is bound to the sulfonium ion that comprises the aryl group (disclosed above) includes an acid labile group substitution (claimed [O-RALU]) and includes a fluorinated group as further substitution. Fukushima, in [0029]-[0033], discloses that the anion (claimed counterion) having the polymerizable group, has the following structure, see below, PNG media_image7.png 108 238 media_image7.png Greyscale , wherein X1, X2, and L4, are each either a single bond or methylene or phenylene or carbonyl or ester group and Q1, Q2, Q3, and Q4, are each fluorine or fluorinated alkyl groups and is the same as the claimed structure recited in claim 4. The difference between the claims and Fukushima is that Fukushima does not disclose that the acid labile group is the structure recited in claim 2. Fujiwara, in [0059]-[0060], discloses that the acid labile group that substitutes the hydrogen on the aryl group (bonded to the sulfonium cation) can include -O-C(=O)-tBu group. Therefore, it would be obvious to a skilled artisan to modify Fukushima to use the acid labile group taught by Fujiwara, because Fukushima teaches that the substitution in the aryl group is with an acid-labile group and Fujiwara, discloses in [0092] that the acid labile group in combination with onium salt compound results in an improvement in contrast (after developing). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Daborah Chacko-Davis whose telephone number is (571) 272-1380. The examiner can normally be reached on 9:30AM-6:00PM EST Mon-Fri. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Mark F. Huff can be reached on (571) 272-1385. The fax phone number for the organization where this application or proceeding is assigned is 571-272-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DABORAH CHACKO-DAVIS/Primary Examiner, Art Unit 1737 January 9, 2026.
Read full office action

Prosecution Timeline

May 12, 2023
Application Filed
Jan 21, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12631961
MONOALKYL TIN TRIALKOXIDES AND/OR MONOALKYL TIN TRIAMIDES WITH LOW METAL CONTAMINATION AND/OR PARTICULATE CONTAMINATION, AND CORRESPONDING METHODS
3y 1m to grant Granted May 19, 2026
Patent 12613462
RESIST PATTERN FORMING METHOD AND SEMICONDUCTOR DEVICE MANUFACTURING METHOD
4y 2m to grant Granted Apr 28, 2026
Patent 12613468
METHOD FOR FORMING PATTERNED PHOTORESIST
2y 5m to grant Granted Apr 28, 2026
Patent 12610788
METHOD OF PROCESSING PHOTORESIST LAYER, AND PHOTORESIST LAYER
3y 9m to grant Granted Apr 21, 2026
Patent 12607925
PELLICLE, EXPOSURE ORIGINAL PLATE, EXPOSURE DEVICE, METHOD OF MANUFACTURING PELLICLE, AND METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE
3y 3m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
92%
With Interview (+20.6%)
3y 4m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 973 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month